- Country or region
- China
- Trade topics
- Public procurement
- Context
- International Procurement Instrument investigations
Summary
- Registration name: IPI China medical devices
- Scope: Medical devices
- Third country concerned: China
- Initiation: 24/04/2024
- Investigation report: 14/01/2025
On 24 April 2024, the European Commission initiated, on its own initiative, pursuant to Article 5(1) of Regulation (EU) 2022/1031 (the IPI Regulation), an investigation into alleged measures and practices of the People’s Republic of China (‘PRC) resulting in a serious and recurrent impairment of access of Union economic operators, goods and services to the PRC’s public procurement market for medical devices.
At the same time, the Commission invited the PRC to enter into consultations to eliminate or remedy the alleged measures and practices.
Member States and interested parties were invited to participate in the investigation and provide relevant information, within 30 calendar days from the date of initiation of the investigation.
See the Notice of Initiation for further details.
On 14 January 2025, in accordance with Article 5(4) of the IPI Regulation, the Commission published a report containing its main findings in the investigation and a proposed course of action (see the report and the Staff Working Document for further details).
Documents
- Notice of Initiation - 24 April 2024
- Letter to interested parties to submit information - 24 April 2024
- Press release - Commission launches first investigation under EU International Procurement Instrument - 24 April 2024
- IPI Report on Chinese procurement market for medical devices and Staff Working Document - 14 January 2025
- Press release - Commission to assess next steps for tackling discrimination in China's public procurement market for medical devices - 14 January 2025